Ameridose, a sister company to the New England Compounding Center, agreed with Massachusetts regulators to extend its closure until Nov. 19 as federal and state investigators continue to inspect its facilities. In addition, state regulators approved emergency regulations to bolster the oversight of drug compounders. The NECC has been linked to an outbreak of meningitis due to contaminated injectable steroids.